Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MoonBiotech

Explore full profile

Guangzhou Based Healthcare Start up

Guangzhou, ChinaFounded 2015Biotech & Life Sciences
Valuation $100–250M Last recorded · 2024
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MoonBiotech and the history behind them.

About MoonBiotech

MoonBiotech, legally registered as Moon (Guangzhou) Biotech Co., Ltd., is a biotechnology firm established in 2015 with a focus on the discovery and commercialization of microbial resources. The company was founded by Jiang Xianzhi, who serves as CEO and brings a strong background in microbiology, holding a doctorate from the University of Chinese Academy of Sciences. His academic and early career as a senior scientist laid the groundwork for the company's scientific direction. The firm originated in Beijing and later established its headquarters in Guangzhou in 2017.

The company's core business revolves around its extensive microbial strain bank, which has grown to house over 320,000 functional strains, positioning it as a significant global resource. MoonBiotech leverages this asset through its proprietary "Culture-To-Product" platform, which facilitates high-throughput screening, application testing, and industrial production of microbe-based products. This platform serves a diverse clientele across the bio-agriculture, bio-medicine, and microbial protein sectors by providing tailored microbial products and solutions. Strategic alliances with multinational corporations like FMC and Syngenta, as well as domestic leaders, underscore its business-to-business model.

A key technological asset is the company's proprietary "Eco-culturomics" technology, which enables the isolation of rare and novel microbes at a rate significantly higher than traditional methods. This capability allows MoonBiotech to develop a varied product portfolio, including microbial seed inoculants and nematode preventers for the agricultural market. The company has successfully raised significant capital to fuel its expansion and commercialization efforts, including a Series C round of CNY 200 million in 2021 and a subsequent Series C+ financing of CNY 300 million in July 2024. These funds are earmarked for scaling up production, commercializing new products, and further enhancing its technology platform and strain bank.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Guangzhou, China
Employees
15
Open positions
None listed
Dealroom signal
55.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Health Diagnostics, Biotech and Pharma, Hard Tech, DT and LS, science-based

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jul 2024 $41M $165M State Development & Investment Corporation (SDIC) ↗
SERIES COther financing Dec 2021 $28M $110M SDIC Venture Capital —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

MoonBiotech website traffic

Latest recorded traffic for MoonBiotech is 270 monthly website visits, down 64.9% over the last three months. MoonBiotech's team grew 0% over the past year.

Latest monthly visits270 3-month web change-64.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Highlight Capital
  • Guangzhou YUEXIU Industrial Investment Fund

Series A2 investors entered at this stage

Series B and later2 investors entered at this stage

  • SDIC Venture Capital
  • State Development & Investment Corporation (SDIC)
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MoonBiotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MoonBiotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.